Silencing the transcriptionally active HIV reservoir to improve treatment outcomes

Affiliations

• ¹ Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA.
• ² Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Research Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA.
• ³ The Skaggs Graduate School of Chemical and Biological Sciences, The Scripps Research Institute, Jupiter, FL, USA.
• ⁴ Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
• ⁵ Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
• ⁶ Department of Urology, University of California San Francisco, San Francisco, CA, USA.
• ⁷ Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. lndhlovu@med.cornell.edu.
• ⁸ Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Research Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA. svalente@ufl.edu.
• ⁹ The Skaggs Graduate School of Chemical and Biological Sciences, The Scripps Research Institute, Jupiter, FL, USA. svalente@ufl.edu.
• ¹⁰ Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.
• ¹¹ Department of Medicine, University of California San Francisco, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.